New non-human primate data show Coave's ligand-conjugated suprachoroidal vector, coAAV-SCS, achieved up to 120-fold higher retinal and ...
Ernexa selected for the Emerging Track, recognizing the Company among emerging innovators in the cell and gene therapy sector ...
A streamlined graph-based tomato pangenome built from cultivated and wild parents has uncovered a new fruit-weight gene and a ...
Cellectis (NASDAQ:CLLS) outlined plans to advance two preclinical in vivo gene-editing candidates for severe forms of dyslipidemia, targeting hypertriglyceridemia and hypercholesterolemia through ...
Marie Claire on MSN
We tapped 101 hair, makeup, and skincare experts to help us judge the 2026 beauty awards
Because we couldn't test 3,500 products alone.
Indian researchers identified non-tuberculous mycobacteria from bovine clinical samples, finding Mycobacterium vaccae to ...
Tuesday, Ernexa Therapeutics ( ERNA) said it has been selected for the Emerging Track at the 2026 Cell & Gene Meeting on the Mesa, where CEO Sanjeev Luther will present the company's oncology strategy ...
Spread the loveThe world of biotechnology just got a seismic shake-up, and it came from an unexpected corner: artificial intelligence. For years, gene editing has been a frontier of human ingenuity, ...
Cellectis to advance two lead in vivo programs .HEAL-101 and .HEAL-201 in severe dyslipidemias with preliminary Phase 1 data planned in H2 2027 and H1 2028, respectively; Transfor ...
Data from a pooled dose group of participants initially enrolled in the multiple ascending dose (MAD) portion of ACHIEVE showed functional ...
In the movie industry, Callahan worked on movies like "Grease 2" in 1982, "Children of a Lesser God" in 1986, "The Stepford ...
Solid Biosciences is leveraging a differentiated SGT-003 gene therapy for Duchenne muscular dystrophy with a credible cash ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results